Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis

Curr Neurol Neurosci Rep. 2020 May 27;20(7):25. doi: 10.1007/s11910-020-01047-1.

Abstract

Purpose of review: In amyotrophic lateral sclerosis (ALS), sleep disruption is frequently present and substantially adds to disease burden. This review aims to summarize current knowledge on causes, pathophysiology, and treatment of sleep disturbances in ALS.

Recent findings: Motor neuron degeneration and muscle weakness may lead to muscle cramps, pain, spasticity, immobilization, restless legs, sleep-disordered breathing, and difficulties to clear secretions. Furthermore, existential fears and depression may promote insomnia. Sleep-disordered breathing, and nocturnal hypoventilation in particular, requires ventilatory support which meaningfully prolongs survival and improves health-related quality of life albeit respiratory failure is inevitable. Early indication for non-invasive ventilation can be achieved by inclusion of capnometry in diagnostic sleep studies. Sleep disruption is extremely common in ALS and may arise from different etiologies. The absence of causative therapeutic options for ALS underlines the importance of symptomatic and palliative treatment strategies that acknowledge sleep-related complaints.

Keywords: Amyotrophic lateral sclerosis; Insomnia; Sleep; Sleep-disordered breathing.

Publication types

  • Review

MeSH terms

  • Amyotrophic Lateral Sclerosis* / complications
  • Amyotrophic Lateral Sclerosis* / epidemiology
  • Amyotrophic Lateral Sclerosis* / therapy
  • Humans
  • Polysomnography
  • Quality of Life
  • Respiratory Insufficiency*
  • Sleep